Currently, mitigating glucose absorption, promoting insulin secretion, alleviating insulin resistance, inhibiting glucagon-like peptide-1 (GLP-1) receptor, sodium-glucose cotransporter-2, and diet control are the predominant modalities of T2D management (5). Here, INS is linked to type 2 diabetes mellitus.